Bile and excipient interactions directing drug pharmacokinetics in rats

Zitieren Sie bitte immer diese URN: urn:nbn:de:bvb:20-opus-296969
  • Bile solubilization plays a major role in the absorption of poorly water-soluble drugs. Excipients used in oral drug formulations impact bile-colloidal properties and their molecular interactions. Polymer-induced changes of bile colloids, e.g., by Eudragit E, reduced the flux of the bile interacting drug Perphenazine whereas bile non-interacting Metoprolol was not impacted. This study corroborates these in vitro findings in rats. Eudragit E significantly reduced systemic availability of Perphenazine but not Metoprolol compared to the oralBile solubilization plays a major role in the absorption of poorly water-soluble drugs. Excipients used in oral drug formulations impact bile-colloidal properties and their molecular interactions. Polymer-induced changes of bile colloids, e.g., by Eudragit E, reduced the flux of the bile interacting drug Perphenazine whereas bile non-interacting Metoprolol was not impacted. This study corroborates these in vitro findings in rats. Eudragit E significantly reduced systemic availability of Perphenazine but not Metoprolol compared to the oral administrations without polymer. This study confirms the necessity to carefully select polymers for bile interacting drugs whereas non-bile interacting drugs are more robust in terms of excipient choice for formulation. The perspective of bile interaction may introduce interesting biopharmaceutical leverage for better performing oral formulations of tomorrow.zeige mehrzeige weniger
Metadaten
Autor(en): Jonas SchlauersbachORCiD, Simon Hanio, Martina Raschig, Bettina Lenz, Oliver Scherf-Cavel, Lorenz Meinel
URN:urn:nbn:de:bvb:20-opus-296969
Dokumentart:Artikel / Aufsatz in einer Zeitschrift
Institute der Universität:Fakultät für Chemie und Pharmazie / Institut für Pharmazie und Lebensmittelchemie
Sprache der Veröffentlichung:Englisch
Titel des übergeordneten Werkes / der Zeitschrift (Englisch):European Journal of Pharmaceutics and Biopharmaceutics
Erscheinungsjahr:2022
Auflage:accepted version
Band / Jahrgang:178
Seitenangabe:65-68
Originalveröffentlichung / Quelle:European Journal of Pharmaceutics and Biopharmaceutics (2022) 178, 65-68. https://doi.org/10.1016/j.ejpb.2022.07.016
DOI:https://doi.org/10.1016/j.ejpb.2022.07.016
Sonstige beteiligte Institutionen:Helmholtz Institute for RNA-based Infection Biology (HIRI), Josef-Schneider-Straße 2/D15, DE-9708 Wuerzburg, Germany
Allgemeine fachliche Zuordnung (DDC-Klassifikation):5 Naturwissenschaften und Mathematik / 54 Chemie / 540 Chemie und zugeordnete Wissenschaften
Freie Schlagwort(e):bile; excipient; in vitro-in vivo correlation; pharmacokinetics; rat study
Datum der Freischaltung:17.12.2022
Embargo-Datum:06.08.2023
Lizenz (Deutsch):License LogoCC BY-NC-ND: Creative-Commons-Lizenz: Namensnennung, Nicht kommerziell, Keine Bearbeitungen 4.0 International